The Effect of Antioxidants on the Immune Response and Wound Healing in Critically Ill Patients
Study Details
Study Description
Brief Summary
The purpose of this study is to investigate whether the addition of omega-3 and antioxidants to nutritional support in critically ill patients in the intensive care unit influences the immune and anti-inflammatory systems and so improves wound healing.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
A prospective randomized study to include 40 consecutive patients admitted to the general intensive care unit. The control group will receive nutritional support composed of a standard formula. The study group will receive nutritional support enriched with fish oil and anti-oxidants. The following variables will be assessed in all patients: demographics, severity of illness, assessment of bed sores. Blood tests will also be taken for the following: CD 8, CD 14, CD 18, CD 11a, CD49c, CD 49d. In addition, blood samples will be collected for TNF, IL-1b, IL-6, IL-8, and levels of C-reactive protein. Metabolic parameters such as resting energy expenditure, BMI, albumin, prealbumin, levels of zinc, relationship between omega 3 and omega 6. Theses test will be performed at time of ICU admission, days 7, 14 and 28 after admission.
The outcome: improved repair of pressure sores, together with improvement in objective parameters of immunity and inflammation.
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: Study Group Enteral Nutrition with Omega 3 (Eicosapentanoic acid, docosahexaenoic acid) |
Dietary Supplement: Eicosapentanoic acid, docosahexaenoic acid
Enteral nutrition formula enriched with Eicosapentanoic acid, docosahexaenoic acid
Other Names:
|
No Intervention: Control Group Patients in control group will receive nutritional support composed of a standard formula |
Outcome Measures
Primary Outcome Measures
- Improvement of wound healing of pressure sores [within 28 days]
Secondary Outcome Measures
- Improvement in parameters of immunity and inflammation [Within 28 days]
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Critically ill patients in intensive care unit
-
Grade 2 pressure sores
Exclusion Criteria:
-
Immunosuppression with steroids or other agents
-
Active bleeding
-
Head trauma
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Rabin Medical center | Petah Tikva | Israel | 49100 |
Sponsors and Collaborators
- Rabin Medical Center
Investigators
- Principal Investigator: Pierre Singer, Rabin Medical Center, Beilison Hospital, Israel
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 4428